Background: Human cytomegalovirus (HCMV) is a herpesvirus with both lytic and latent life cycles. Human cytomegalovirus encodes 2 viral cytokines that are orthologs of human cellular interleukin 10 (cIL-10). Both cytomegalovirus interleukin 10 (cmvIL-10) and Latency-associated cytomegalovirus interleukin 10 (LAcmvIL-10) (collectively vIL-10) are expressed during lytic infection and cause immunosuppressive effects that impede virus clearance. LAcmvIL-10 is also expressed during latent infection of myeloid progenitor cells and monocytes and facilitates persistence. Here, we investigated whether vIL-10 could be detected during natural infection. Methods: Plasma from healthy blood donors was tested by enzyme-linked immunosorbent assay for anti-HCMV immunoglobulin G and immunoglobulin M and for cIL-10 and vIL-10 levels using a novel vIL-10 assay that detects cmvIL-10 and LAcmvIL-10, with no cross-reactivity to cIL-10. Results: vIL-10 was evident in HCMV+ donors (n = 19 of 26), at levels ranging 31-547 pg/mL. By comparison, cIL-10 was detected at lower levels ranging 3-69 pg/mL. There was a strong correlation between vIL-10 and cIL-10 levels (P = .01). Antibodies against vIL-10 were also detected and neutralized vIL-10 activity. Conclusions: vIL-10 was detected in peripheral blood of healthy blood donors. These findings suggest that vIL-10 may play a key role in sensing or modifying the host environment during latency and, therefore, may be a potential target for intervention strategies.
Background: Human cytomegalovirus (HCMV) is a herpesvirus with both lytic and latent life cycles. Human cytomegalovirus encodes 2 viral cytokines that are orthologs of human cellular interleukin 10 (cIL-10). Both cytomegalovirus interleukin 10 (cmvIL-10) and Latency-associated cytomegalovirus interleukin 10 (LAcmvIL-10) (collectively vIL-10) are expressed during lytic infection and cause immunosuppressive effects that impede virus clearance. LAcmvIL-10 is also expressed during latent infection of myeloid progenitor cells and monocytes and facilitates persistence. Here, we investigated whether vIL-10 could be detected during natural infection. Methods: Plasma from healthy blood donors was tested by enzyme-linked immunosorbent assay for anti-HCMV immunoglobulin G and immunoglobulin M and for cIL-10 and vIL-10 levels using a novel vIL-10 assay that detects cmvIL-10 and LAcmvIL-10, with no cross-reactivity to cIL-10. Results:vIL-10 was evident in HCMV+ donors (n = 19 of 26), at levels ranging 31-547 pg/mL. By comparison, cIL-10 was detected at lower levels ranging 3-69 pg/mL. There was a strong correlation between vIL-10 and cIL-10 levels (P = .01). Antibodies against vIL-10 were also detected and neutralized vIL-10 activity. Conclusions: vIL-10 was detected in peripheral blood of healthy blood donors. These findings suggest that vIL-10 may play a key role in sensing or modifying the host environment during latency and, therefore, may be a potential target for intervention strategies.
Authors: Mark N Polizzotto; Thomas S Uldrick; Victoria Wang; Karen Aleman; Kathleen M Wyvill; Vickie Marshall; Stefania Pittaluga; Deirdre O'Mahony; Denise Whitby; Giovanna Tosato; Seth M Steinberg; Richard F Little; Robert Yarchoan Journal: Blood Date: 2013-10-30 Impact factor: 22.113
Authors: M D Tolpin; J A Stewart; D Warren; B A Mojica; M A Collins; S A Doveikis; C Cabradilla; V Schauf; T N Raju; K Nelson Journal: J Pediatr Date: 1985-12 Impact factor: 4.406
Authors: Efe Sezgin; Douglas A Jabs; Sher L Hendrickson; Mark Van Natta; Alexander Zdanov; Richard Alan Lewis; Michael W Smith; Jennifer L Troyer; Stephen J O'Brien Journal: J Infect Dis Date: 2010-08-15 Impact factor: 5.226
Authors: Juliet V Spencer; Kristen M Lockridge; Peter A Barry; Gaofeng Lin; Monica Tsang; Mark E T Penfold; Thomas J Schall Journal: J Virol Date: 2002-02 Impact factor: 5.103
Authors: Meghan K Eberhardt; W L William Chang; Naomi J Logsdon; Yujuan Yue; Mark R Walter; Peter A Barry Journal: PLoS One Date: 2012-05-24 Impact factor: 3.240
Authors: Jesse D Deere; W L William Chang; Andradi Villalobos; Kimberli A Schmidt; Ashlesha Deshpande; Luis D Castillo; Joseph Fike; Mark R Walter; Peter A Barry; Dennis J Hartigan-O'Connor Journal: Proc Natl Acad Sci U S A Date: 2019-06-12 Impact factor: 11.205
Authors: Maxim Cherneha; Johannes Korth; Meike Kaulfuß; Mirko Trilling; Marek Widera; Hana Rohn; Sebastian Dolff; Nina Babel; André Hoerning; Andreas Kribben; Oliver Witzke Journal: Viruses Date: 2021-03-06 Impact factor: 5.048